HIVE Digital Technologies (HIVE) CEO details options, RSUs and shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
HIVE Digital Technologies Ltd. President & CEO Kilic Aydin filed an initial ownership report detailing his equity interests in the company. The filing lists indirect holdings through Akilic Ventures Ltd. and Unimage Enterprises Ltd., including stock options, restricted stock units and common shares, plus a small block of common stock held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
11 transactions reported
Mixed
11 txns
Insider
Kilic Aydin
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Options (right to buy) — 180,000 shares (Indirect, Akilic Ventures Ltd.);
Restricted Stock Units — 150,000 shares (Indirect, Akilic Ventures Ltd.);
Common Stock — 300 shares (Direct);
Common Stock — 716,777 shares (Indirect, By Akilic Ventures Ltd.)
Footnotes (1)
- These securities are owned by Akilic Ventures Ltd., a corporation that is wholly-controlled by Mr. Kilic. These securities are owned by Unimage Enterprises Ltd., a corporation that is wholly-controlled by Mr. Kilic. These options were granted on October 7, 2021. 162,000 options have vested as of the date hereof, and the remaining 18,000 will vest in two equal installments on May 19, 2026 and August 19, 2026. Represents an exercise price of $18.50 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on August 6, 2022 and are fully vested as of the date hereof. Represents an exercise price of $5.66 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on July 6, 2023 and are fully vested as of the date hereof. Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024. 150,00 of the RSUs remain outstanding, and will vest in 3 equal installments on each of May 5, 2026, August 5, 2026, and November 5, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.
Key Figures
Options exercise price: $13.33 per share
Options exercise price: $4.08 per share
Options exercise price: $4.94 per share
+4 more
7 metrics
Options exercise price
$13.33 per share
180,000 underlying HIVE common shares; expiration on October 7, 2031
Options exercise price
$4.08 per share
72,000 underlying HIVE common shares; expiration on August 26, 2027
Options exercise price
$4.94 per share
75,000 underlying HIVE common shares; expiration on July 6, 2028
RSU grant
150,000 RSUs
Issued November 5, 2024; vesting in three equal installments in 2026
Common shares indirect
716,777 shares
HIVE common stock held by Akilic Ventures Ltd.
Common shares indirect
1,200 shares
HIVE common stock held by Unimage Enterprises Ltd.
Common shares direct
300 shares
HIVE common stock held directly by Kilic Aydin
Key Terms
Restricted Stock Unit ("RSU"), exercise price, vest, initial statement of beneficial ownership, +1 more
5 terms
Restricted Stock Unit ("RSU") financial
"Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock."
exercise price financial
"Represents an exercise price of $18.50 Canadian dollars, converted to U.S. dollars at the daily average exchange rate..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"162,000 options have vested as of the date hereof, and the remaining 18,000 will vest in two equal installments..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
initial statement of beneficial ownership regulatory
"Form 3 is the initial statement of beneficial ownership of securities by an insider."
indirect ownership financial
"These securities are owned by Akilic Ventures Ltd., a corporation that is wholly-controlled by Mr. Kilic."
FAQ
What does the HIVE Form 3 filing by CEO Kilic Aydin show?
The Form 3 shows Kilic Aydin’s existing ownership in HIVE, including options, restricted stock units and common shares. It is an initial ownership report, not a record of new buying or selling activity.
How many HIVE options does Kilic Aydin hold through Akilic Ventures Ltd.?
Akilic Ventures Ltd., wholly controlled by Kilic Aydin, holds options over 180,000 HIVE common shares at an exercise price of $13.33, 72,000 shares at $4.08 and 75,000 shares at $4.94, with expiration dates between 2027 and 2031.
What restricted stock units (RSUs) tied to HIVE common stock are reported?
The filing lists several RSU awards, each representing one HIVE common share at settlement. These RSUs were granted between November 2024 and March 2026, with vesting dates in 2026 and 2027, and are held indirectly through entities controlled by Kilic Aydin.
What direct HIVE common stock does CEO Kilic Aydin own?
The filing shows Kilic Aydin directly holds 300 HIVE common shares. Additional common shares are held indirectly through Akilic Ventures Ltd. and Unimage Enterprises Ltd., which are corporations wholly controlled by him.
When do HIVE CEO stock options and RSUs reported on Form 3 vest or expire?
Certain options were granted between 2021 and 2023 and are fully or mostly vested, with expirations from August 2027 to October 2031. RSUs granted from 2024 to 2026 vest on specific dates between May 2026 and March 2027.